Evolution of the Average Target: Bastide Le Confort Médical

Evolution of the Target Price: Bastide Le Confort Médical

Changes in Analyst Recommendations: Bastide Le Confort Médical

7.4EdmPP0Pk1h0ARwSMr0O8JFWA-XSTPyNhgI7Zq1F1IA.mRUPULZt-jBNcV0_AOVAoPJiVo_kKLW10lVSLPwoota0Mw9QqFDLFUcsew~99c9983b3b21507af07d864ad4ab44ed
09-04 Bastide Le Confort Medical: FY sales beat guidance - end of coverage on 1st of October Alphavalue
05-18 Baader Europe maintains stance on Bastide le Confort Médical Zonebourse
05-15 Bastide Le Confort Medical: Guidance confirmed despite transitory regulatory headwinds in Q3 Alphavalue
03-19 Bastide Le Confort Medical: Sound H1 results, solid deleveraging, and reaffirmed FY guidance Alphavalue
03-19 Bastide results in line with guidance, says Oddo BHF Zonebourse
12-05 Bastide Le Confort Medical cuts EPS guidance Alphavalue
27/10/25 Bastide Le Confort Medical: In-line FY24/25 underlying results; smooth deleveraging Alphavalue
05/09/25 Bastide Le Confort Medical: In-line FY24/25 revenue; reconfirmed guidance Alphavalue
04/07/25 Bastide Le Confort Medical: Impact of strategic divestitures effective from next FY Alphavalue
06/06/25 Bastide: Oddo BHF still a buyer Zonebourse
16/05/25 Bastide Le Confort Medical: Reconfirmed guidance backed by compelling 9M turnover Alphavalue
20/03/25 Bastide Le Confort Medical: EPS cut (2024: -52.7%, 2025: -37.4%) Alphavalue
20/03/25 Bastide Le Confort Medical: Profitability gains neutralized by heavier financial expenses Alphavalue
20/03/25 Bastide: price target raised by Oddo BHF Zonebourse
14/03/25 Bastide Le Confort Medical: Debt reduction on the right trajectory Alphavalue
14/02/25 Bastide Le Confort Medical: Crystallizing a better revenue mix Alphavalue
27/11/24 Bastide: up sharply, a broker raises his recommendation Zonebourse
27/11/24 Bastide: Oddo BHF upgrades to 'outperform', raises target Zonebourse
15/11/24 Bastide Le Confort Medical: Better revenue mix; progress in portfolio review Alphavalue
28/10/24 Bastide Le Confort Medical: Margin build-up and debt reduction on a good trajectory Alphavalue
30/08/24 Bastide Le Confort Medical: Stronger qoq organic growth; guidance reiterated Alphavalue
15/05/24 Bastide Le Confort Medical: De facto maintained guidance; more disposals to propel debt reduction Alphavalue
09/04/24 Bastide Le Confort Medical: EPS upgrade (2023: 0.0%, 2024: +1.6%) Alphavalue
21/03/24 Bastide Le Confort Medical: The prioritised debt reduction awaits further visible progress Alphavalue
15/02/24 Bastide Le Confort Medical: Reiterated guidance and further progress on the in debt profile Alphavalue

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - +36.56%
+27.34%
+12.97%
+17.85%
- +17.73%
Average +22.49%
Weighted average by Cap. +24.75%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
22.70EUR
Average target price
31.00EUR
Spread / Average Target
+36.56%
High Price Target
31.00EUR
Spread / Highest target
+36.56%
Low Price Target
31.00EUR
Spread / Lowest Target
+36.56%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
-
Investor
Global
-
Quality
ESG MSCI
-
  1. Stock Market
  2. Stocks
  3. BLC Stock
  4. Consensus Bastide Le Confort Médical
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!